Market Place
Sourcing Support
Adagene Doses First Patient in Ph2 Muzastotug Combo Study
31 Oct 2025 //
GLOBENEWSWIRE
Synthekine to Present STK-012 Combo Data in NSCLC at SITC 2025
30 Oct 2025 //
BUSINESSWIRE
Destiny-Lung06 Trial Begins: Enhertu Phase 3 For 1St-Line HER2
30 Oct 2025 //
BUSINESSWIRE
EC Approves Keytruda Combo for PD-L1+Resectable Head&Neck Cancer
29 Oct 2025 //
BUSINESSWIRE
Merck, Eisai End Keytruda-Lenvima Collaboration In Liver Cancer
29 Oct 2025 //
FIERCE PHARMA
Welireg`s RCC Wins Could Pad Merck`s Post-Keytruda Sales
28 Oct 2025 //
FIERCE PHARMA
FDA Prioritizes KEYTRUDA And KEYTRUDA QLEX Combo with Padcev
23 Oct 2025 //
BUSINESSWIRE
MDNA11 Clinical Data From ABILITY-1 Study At ESMO 2025
23 Oct 2025 //
GLOBENEWSWIRE
HCW Biologics Joins Virtual Investor Segment
22 Oct 2025 //
GLOBENEWSWIRE
Keytruda, Lenvima Show Long-Term Survival Benefit in Cancer
22 Oct 2025 //
INDPHARMAPOST
Flare Pharma Collaborates with Merck for Fx-909 and Keytruda
21 Oct 2025 //
GLOBENEWSWIRE
KEYTRUDA® Shows Prolonged Survival Benefit In Some NSCLC Patients
20 Oct 2025 //
BUSINESSWIRE
Immunos Therapeutics Shows IOS-1002 Promise In Advanced Solid
20 Oct 2025 //
PHARMIWEB
Transgene & BioInvent’s BT-001 Shows Strong Antitumor Activity
20 Oct 2025 //
ACCESSWIRE
Niios Pharma Presents NI-1801 Data For Platinum-Resistant Cancer
20 Oct 2025 //
PHARMIWEB
IO Biotech Present Phase 3 Cylembio+ Keytruda Results
20 Oct 2025 //
GLOBENEWSWIRE
Keytruda and Lenvima Show Long-Term Survival Benefit
18 Oct 2025 //
BUSINESSWIRE
KEYTRUDA® Combo Reduces Progression Risk In Platinum-Resistant
18 Oct 2025 //
BUSINESSWIRE
Keytruda, Padcev Cut Risk Of Death By 50% In MIBC Patient Subset
18 Oct 2025 //
FIERCE PHARMA
ESMO: Merck Lays Out Keytruda`s Landmark Win In Ovarian Cancer
18 Oct 2025 //
FIERCE PHARMA
Merck`s KEYNOTE-B96 Phase 3 Trial Meets Secondary Endpoint
16 Oct 2025 //
BUSINESSWIRE
In Ovarian Cancer, Keytruda Follows PFS Win With Survival Showing
16 Oct 2025 //
FIERCE PHARMA
Nucana Reports Positive NUC-3373 Data With Anti-PD-1 Therapy
15 Oct 2025 //
PHARMIWEB
Bicara Pharma`s Ficerafusp Alfa Earns Breakthrough Designation
13 Oct 2025 //
GLOBENEWSWIRE
Transgene, Bioinvent To Unveil BT-001, Oncolytic Virus Data
13 Oct 2025 //
ACCESSWIRE
Moderna Claims Early Victory For Cancer Antigen In Melanoma
13 Oct 2025 //
BIOSPACE
Moderna Unveils Positive Early Results For Cancer Antigen Therapy
12 Oct 2025 //
PHARMIWEB
Nouscom Reveals NOUS-209 Immunotherapy Success In MSI-H Cancer
12 Oct 2025 //
GLOBENEWSWIRE
Merck Expands Keytruda`s Role In Cancer Innovation To New Tumor
11 Oct 2025 //
INDPHARMAPOST
Merck Advances Oncology Innovation At ESMO 2025
09 Oct 2025 //
PHARMIWEB
Immutep Shares Update on Ph3 TACTI-004 Trial in Lung Cancer
09 Oct 2025 //
GLOBENEWSWIRE
Bioinvent Starts BI-1206 Ph 2a Trial In Advanced NSCLC & Melanoma
08 Oct 2025 //
PR NEWSWIRE
Tango Therapeutics To Unveil TNG260 Clinical Data at SITC 2025
06 Oct 2025 //
GLOBENEWSWIRE
Eisai to Present 5-Year KEYNOTE-775 Data at ESMO 2025
02 Oct 2025 //
PR NEWSWIRE
Incendia Therapeutics Showcases PRTH-101 In Thymic Cancers
02 Oct 2025 //
GLOBENEWSWIRE
Astellas Showcases Innovations At ESMO 2025
01 Oct 2025 //
PR NEWSWIRE
Judy Wang, Md Leads Manuscript On Enhancing Immunotherapy
25 Sep 2025 //
PR NEWSWIRE
Microbiotica Completes Global Phase 1b of MB097 Trial Enrollment
24 Sep 2025 //
PHARMAWEB
Io Biotech`s Advanced Melanoma Abstract Chosen For Esmo Congress
23 Sep 2025 //
GLOBENEWSWIRE
Microbiotica Completes Recruitment for Intl Ph 1b Trial of MB097
19 Sep 2025 //
PHARMAWEB
FDA Approves Merck`s Injectable Version of Blockbuster Keytruda
19 Sep 2025 //
REUTERS
PDS Bio Achieves Extended Survival in Head and Neck Cancer Trial
18 Sep 2025 //
GLOBENEWSWIRE
HCW Biologics Designates TRBC-Pembro Inhibitor As Lead Therapy
16 Sep 2025 //
GLOBENEWSWIRE
Immutep to Present Ph2 EFTISARC-NEO Efti Data in Sarcoma at CTOS
08 Sep 2025 //
GLOBENEWSWIRE
Adagene`s ADG126 Highlighted in Two Presentations at 2025 CSCO
05 Sep 2025 //
GLOBENEWSWIRE
Akeso Completes Ph3 Enrollment for Ivonescimab in Biliary Cancer
02 Sep 2025 //
PR NEWSWIRE
PDS Biotech`s Data VERSATILE-002 Phase 2 Head and Neck Cancer
25 Aug 2025 //
GLOBENEWSWIRE
Padcev-Keytruda Combo Delivers Bladder Cancer `breakthrough`
13 Aug 2025 //
PRESS RELEASE
Transgene, BioInvent to Share BT-001 Oncolytic Virus Data at ESMO
28 Jul 2025 //
ACCESSWIRE
Immutep Abstracts Accepted for 2025 ESMO Congress
28 Jul 2025 //
GLOBENEWSWIRE
NMPA Accepts sNDA for Ivonescimab Combo in Advanced Lung Cancer
28 Jul 2025 //
PR NEWSWIRE
Merck`s Biologics Keytruda Receives Suppl Approval in US
24 Jul 2025 //
FDA
Cantargia Shares Nadunolimab Lung Cancer Combo Data
16 Jul 2025 //
ACCESSWIRE
Cue Biopharma Announces 50% Response in Phase 1 Trial of CUE-101
16 Jul 2025 //
GLOBENEWSWIRE
Aethlon Medical Gets Approval to Advance to Clinical Trial Stage
15 Jul 2025 //
PR NEWSWIRE
China`s 9-valent HPV vaccine priced at 60% discount to Merck jab
10 Jul 2025 //
FIERCE PHARMA
FDA Grants FF-10832 Orphan Drug Status for Biliary Tract Cancer
07 Jul 2025 //
BUSINESSWIRE
BeyondSpring`s Plinabulin Drives Dendritic Cell Maturation
07 Jul 2025 //
GLOBENEWSWIRE
Cue Biopharma Updates CUE-101 at DAVA 4th Hawaii Global Summit
01 Jul 2025 //
GLOBENEWSWIRE
Corbus Doses First Patient in CRB-701 + Pembrolizumab Trial
25 Jun 2025 //
GLOBENEWSWIRE
